Nicolau, D. P., Onyeji, C. O., Zhong, M., Tessier, P. R., Banevicius, M. A., & Nightingale, C. H. (2000). Pharmacodynamic Assessment of Cefprozil against Streptococcus pneumoniae: Implications for Breakpoint Determinations. American Society for Microbiology.
Chicago Style CitationNicolau, David P., Cyprian O. Onyeji, Mingkang Zhong, Pamela R. Tessier, Mary Anne Banevicius, i Charles H. Nightingale. Pharmacodynamic Assessment of Cefprozil against Streptococcus Pneumoniae: Implications for Breakpoint Determinations. American Society for Microbiology, 2000.
Cita MLANicolau, David P., et al. Pharmacodynamic Assessment of Cefprozil against Streptococcus Pneumoniae: Implications for Breakpoint Determinations. American Society for Microbiology, 2000.